2-(2-phenylmethoxycyclohexyl)-3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]pyrazolo[3,4-d]pyrimidin-4-amine
C24H23F3N6O2 — CID 146447716
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2-phenylmethoxycyclohexyl)-3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]pyrazolo[3,4-d]pyrimidin-4-amine
2-(2-phenylmethoxycyclohexyl)-3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]pyrazolo[3,4-d]pyrimidin-4-amine (PubChem CID 146447716) has the molecular formula C24H23F3N6O2 and a molecular weight of 484.48 g/mol. Its IUPAC name is 2-(2-phenylmethoxycyclohexyl)-3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]pyrazolo[3,4-d]pyrimidin-4-amine.
Molecular Properties
| Compound Name | 2-(2-phenylmethoxycyclohexyl)-3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]pyrazolo[3,4-d]pyrimidin-4-amine |
|---|---|
| PubChem CID | 146447716 |
| Molecular Formula | C24H23F3N6O2 |
| Molecular Weight | 484.48 g/mol |
| Exact Mass | 484.18 |
| IUPAC Name | 2-(2-phenylmethoxycyclohexyl)-3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]pyrazolo[3,4-d]pyrimidin-4-amine |
| SMILES | Nc1ncnc2nn(C3CCCCC3OCc3ccccc3)c(Oc3cc(C(F)(F)F)ccn3)c12 |
| InChI | InChI=1S/C24H23F3N6O2/c25-24(26,27)16-10-11-29-19(12-16)35-23-20-21(28)30-14-31-22(20)32-33(23)17-8-4-5-9-18(17)34-13-15-6-2-1-3-7-15/h1-3,6-7,10-12,14,17-18H,4-5,8-9,13H2,(H2,28,30,31,32) |
| InChIKey | PBQUWKRHXYFUGM-UHFFFAOYSA-N |
| XLogP | 5.32 |
| TPSA | 100.97 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 484.48 |
| LogP ≤ 5 | 5.32 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146447716 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.